Clinical trial
Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study That Evaluates the Effects of Pravastatin for Acute Myocardial Infarction With LDL-Cholesterol Levels of 70-129 mg/dl
NCT00688922 is registered in ClinicalTrials.gov with Osaka Acute Coronary Insufficiency Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study That Evaluates the Effects of Pravastatin for Acute Myocardial Infarction With LDL-Cholesterol Levels of 70-129 mg/dl
- Lead sponsor
- Osaka Acute Coronary Insufficiency Study Group
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2008
- Completion date
- June 30, 2011
- Enrollment
- 400 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction